COR
Cencora, Inc.
Key Financials
Revenue
$321.3B
↑ 9.3%
Net Income
$1.6B
↑ 3.0%
Operating Income
$2.6B
↑ 20.8%
Gross Profit
$11.5B
↑ 15.8%
EPS (Diluted)
$7.96
↑ 5.7%
Total Assets
$76.6B
↑ 14.1%
Cash & Equivalents
$4.4B
↑ 39.1%
Shareholders' Equity
$1.5B
↑ 133.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 4/2/2026 | View on SEC |
| SCHEDULE 13G/A | 3/26/2026 | View on SEC |
| 8-K | 3/23/2026 | View on SEC |
| 8-K | 3/17/2026 | View on SEC |
| 4 | 3/13/2026 | View on SEC |
| 4 | 3/13/2026 | View on SEC |
| 4 | 3/13/2026 | View on SEC |
| 4 | 3/9/2026 | View on SEC |
| 4 | 3/9/2026 | View on SEC |
| 4 | 3/9/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | COR |
| Company Name | Cencora, Inc. |
| CIK | 1140859 |
| Sector | Wholesale-Drugs, Proprietaries & Druggists' Sundries |
| Industry | Large accelerated filer |
| Exchange | NYSE |
| SIC Code | 5122 |
| SIC Description | Wholesale-Drugs, Proprietaries & Druggists' Sundries |
| Entity Type | operating |
| Fiscal Year End | 0930 |
| State of Incorporation | DE |
| Phone | 610-727-7000 |